within Pharmacolibrary.Drugs.ATC.P;

model P01BC02
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.89,
    Cl             = 3.5000000000000004e-07,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0132,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00075,
    Tlag           = 1200,            
    Vdp             = 0.398,
    k12             = 3.4,
    k21             = 3.4
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>P01BC02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Mefloquine is an antimalarial medication used for the treatment and prevention of malaria, particularly caused by Plasmodium falciparum. It is typically used as a prophylactic agent for travelers to endemic regions and as a treatment for uncomplicated malaria. Mefloquine is approved and used in clinical practice but its use is limited by potential neuropsychiatric side effects.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Karbwang, J, &amp; Na-Bangchang, K (1994). Clinical application of mefloquine pharmacokinetics in the treatment of P falciparum malaria. <i>Fundamental &amp; clinical pharmacology</i> 8(6) 491–502. DOI:<a href=\"https://doi.org/10.1111/j.1472-8206.1994.tb00830.x\">10.1111/j.1472-8206.1994.tb00830.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7721226/\">https://pubmed.ncbi.nlm.nih.gov/7721226</a></p></li><li><p>Ferreira, MVD, et al., &amp; de Siqueira, AM (2018). Pharmacokinetics of mefloquine administered with artesunate in patients with uncomplicated falciparum malaria from the Brazilian Amazon basin. <i>Malaria journal</i> 17(1) 268–None. DOI:<a href=\"https://doi.org/10.1186/s12936-018-2416-0\">10.1186/s12936-018-2416-0</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30012152/\">https://pubmed.ncbi.nlm.nih.gov/30012152</a></p></li><li><p>Karbwang, J, et al., &amp; Breckenridge, AM (1988). Effect of oral contraceptive steroids on the clinical course of malaria infection and on the pharmacokinetics of mefloquine in Thai women. <i>Bulletin of the World Health Organization</i> 66(6) 763–767. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3266115/\">https://pubmed.ncbi.nlm.nih.gov/3266115</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end P01BC02;
